Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
218M
-
Number of holders
-
283
-
Total 13F shares, excl. options
-
144M
-
Shares change
-
+139M
-
Total reported value, excl. options
-
$5.74B
-
Value change
-
+$5.57B
-
Put/Call ratio
-
0.69
-
Number of buys
-
276
-
Number of sells
-
-4
-
Price
-
$40.15
Significant Holders of QIAGEN N.V. - Common Stock (QGEN) as of Q1 2025
298 filings reported holding QGEN - QIAGEN N.V. - Common Stock as of Q1 2025.
QIAGEN N.V. - Common Stock (QGEN) has 283 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 144M shares
of 218M outstanding shares and own 65.83% of the company stock.
Largest 10 shareholders include MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (25.3M shares), WELLINGTON MANAGEMENT GROUP LLP (24.4M shares), VANGUARD GROUP INC (8.88M shares), BlackRock, Inc. (5.47M shares), DEUTSCHE BANK AG\ (4.49M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.47M shares), AMUNDI (4.35M shares), EARNEST PARTNERS LLC (3.81M shares), BANK OF AMERICA CORP /DE/ (3.39M shares), and NUANCE INVESTMENTS, LLC (2.78M shares).
This table shows the top 283 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.